London Daily

Focus on the big picture.
Monday, Jul 21, 2025

Covid: PM confident of no problem over India jab travel

Covid: PM confident of no problem over India jab travel

Boris Johnson has said he is "very confident" there "will not prove to be a problem" for travellers who have received an Indian-made Covid jab.

It comes after reports the European Union's passport scheme does not recognise the AstraZeneca vaccine made by the Serum Institute of India.

The UK's medicines regulator has shared its data on the jab with its European counterpart, Downing Street said.

Vaccine expert Prof Adam Finn said the vaccines were "exactly the same stuff".

The Daily Telegraph had reported that millions of people who have received doses from batches manufactured in India could face being blocked from taking European holidays.

The UK has received five million doses of the AstraZeneca vaccine from the Serum Institute, which manufactures the jab under the name Covishield - although that name is not used in the UK.

The Serum Institute has not received approval to make the Covid jab from the European drugs regulator but has been cleared by the UK's Medicines and Healthcare products Regulatory Agency (MHRA).

However, the Department of Health and Social Care (DHSC) said all AstraZeneca vaccines administered in the UK would appear under the brand name Vaxzevria - the same as the AstraZeneca jab produced elsewhere - on the NHS Covid Pass.

It said "no Covishield jabs have been administered in the UK".

On Friday the UK recorded 27,125 new cases of coronavirus and a further 27 deaths within 28 days of a positive test.

Currently the EU is rolling out a Digital Covid Certificate so travellers can prove their vaccination status in order to be exempt from quarantining when crossing an international border.

A European Commission spokesman said that while entry to the EU should be allowed to those who are fully vaccinated with EU authorised jabs, member states could make their own decision on whether to allow entry for people vaccinated with jabs on the World Health Organization's emergency list - which includes Covishield.

Several European countries have already approved the Covishield jab for travel. These include Austria, Germany, Slovenia, Greece, the Republic of Ireland, Spain, Iceland and Switzerland.

At the moment the EU does not accept the UK's NHS app for Covid certification but a UK government spokesman said it will be "a key service" as international travel is reopened.

Individual countries including Greece and Spain do accept it.

With batch numbers being visible via the UK's Covid pass it is not clear if officials EU countries could check if a person had received a dose originating in India.

Earlier, Downing Street said the MHRA had shared its assessment of the vaccines with its European counterpart - the European Medicines Agency (EMA) - to assist the approvals process.

During a press conference with German Chancellor Angel Merkel, the UK prime minister, Mr Johnson, said he saw "no reason at all" why MHRA-approved vaccines should not be used for vaccine passports.

Mrs Merkel said that "in the foreseeable future" those with double jabs in high incidence areas, like Britain, "will be able to travel again without having to go into quarantine".

The Serum Institute is reportedly seeking emergency authorisation from Europe for the Covishield jab, which has widely been distributed in poorer countries as part of the Covavax scheme.

AstraZeneca also says it is working with the EMA on the "inclusion of Covishield as a recognised vaccine for immunisation passports" - although the EMA says there is currently no application for market authorisation.

Prof Finn, a member of the UK's Joint Committee on Vaccination and Immunisation (JCVI), told BBC Radio 4's Today programme people should not be worried that they were any less protected by the Covishield jab and said the "administrative hurdle" should be "straightened out".

"We're in the early days of this new world of needed vaccine passports and there are lots of aspects of this that are still being sorted out for the first time," he said.

"But it's clearly, ultimately not in anyone's interest, including the European Union, to create hurdles that don't need to be there."

Newsletter

Related Articles

0:00
0:00
Close
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
Epstein Files Deepen Republican Party Divide
Zuckerberg Faces $8 Billion Privacy Lawsuit From Meta Shareholders
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
SpaceX Nears $400 Billion Valuation With New Share Sale
Microsoft, US Lab to Use AI for Faster Nuclear Plant Licensing
Trump Walks Back Talk of Firing Fed Chair Jerome Powell
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Irish Tech Worker Detained 100 days by US Authorities for Overstaying Visa
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Jeff Bezos Considers Purchasing Condé Nast as a Wedding Gift
Ghislaine Maxwell Says She’s Ready to Testify Before Congress on Epstein’s Criminal Empire
Bal des Pompiers: A Celebration of Community and Firefighter Culture in France
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
Google Secures Windsurf AI Coding Team in $2.4 Billion Licence Deal
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
South African Police Minister Suspended Amid Organised Crime Allegations
Nvidia CEO Claims Chinese Military Reluctance to Use US AI Technology
Hong Kong Advances Digital Asset Strategy to Address Economic Challenges
Australia Rules Out Pre‑commitment of Troops, Reinforces Defence Posture Amid US‑China Tensions
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
U.S. Resumes Deportations to Third Countries After Supreme Court Ruling
Excavation Begins at Site of Mass Grave for Children at Former Irish Institution
Iranian President Reportedly Injured During Israeli Strike on Secret Facility
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Defends Attorney General Pam Bondi Amid Epstein Memo Backlash
Renault Shares Drop as CEO Luca de Meo Announces Departure Amid Reports of Move to Kering
Senior Aides for King Charles and Prince Harry Hold Secret Peace Summit
Anti‑Semitism ‘Normalised’ in Middle‑Class Britain, Says Commission Co‑Chair
King Charles Meets David Beckham at Chelsea Flower Show
If the Department is Really About Justice: Ghislaine Maxwell Should Be Freed Now
NYC Candidate Zohran Mamdani’s ‘Antifada’ Remarks Spark National Debate on Political Language and Economic Policy
×